Track topics on Twitter Track topics that are important to you
Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings articles that have been published worldwide.
We have published hundreds of Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings news stories on BioPortfolio along with dozens of Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings Clinical Trials and PubMed Articles about Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings Companies in our database. You can also find out about relevant Cytori Therapeutics CYTX Marc Hedrick 2017 Results Earnings Drugs and Medications on this site too.
Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effective treatment is most needed, but these infections are hard to manage, and progress has been limited. Here, we explore a different approach. Applying an evolutionary perspective to a review of antibiotic prescription studies, we identify infections that likely make a large contribution to resistance evolution ac...
The purpose of this letter is to refute the comments written by Smits, Goverts, and Versfeld (2017).
This study examines how women's asset ownership is associated with children's nutritional status in Papua New Guinea, a country with some of the most severe child malnutrition in the world. The 2009-2010 Household Income and Expenditure Survey is employed, but restricted to children under the age of 72 months living with married mothers, leaving a final analytic sample of 1651. Asset ownership is expected to strengthen mothers' income-generating capacity and their bargaining power within the home, which inc...
In 2017, a new paradigm change caused by artificial intelligence and big data analysis resulted in innovation in each field of science and technology, and also significantly influenced progress in tissue engineering and regenerative medicine (TERM). TERM has continued to make technological advances based on interdisciplinary approaches and has contributed to the overall field of biomedical technology including cancer biology, personalized medicine, development biology, and cell-based therapeutics. While res...
'Influence of genetic variants of IDH1, IDH2, TET2 and DNMT3A on cytarabine cytotoxicity in different populations' by Y. Wang & J. K. LambaThe above article from the Journal of Clinical Pharmacy and Therapeutics, published online on 21 November 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted following discussions with the authors, the Journal Editors and John Wiley & Sons Ltd. The Retraction has been agreed as this paper was submitted under the joint names of Yan Wang, Jatinder K. ...
International Journal of Obesity accepted article preview online, 06 December 2017. doi:10.1038/ijo.2017.290.
While the therapeutic biologics are dominated by therapeutic proteins, particularly monoclonal antibodies, a wide range of non-protein therapeutic biologics are rapidly gaining ground both in clinical studies and approved products. Many of these first-in-class therapies provide novel treatment modalities and address previously untreatable conditions or undruggable targets. In particular, novel treatments for rare genetic disorders and qualitatively different oncology therapeutics have been approved in the l...
The direct and indirect costs of dermatology clinic visits are infrequently quantified. Indirect costs, such as the time spent traveling to and from appointments and the value of lost earnings from time away from work, are substantial costs that often are not included in economic analyses but may pose barriers to receiving care. Due to the national shortage of dermatologists, patients may have to wait longer for appointments or travel further to see dermatologists outside of their local community, resulting...
Type 2 diabetes (T2D) imposes a substantial disease burden, predominantly from cardiovascular disease (CVD), which accounts for >50% of deaths in this population and leads to a 12-year reduction in the life expectancy of a 60-year-old male patient with T2D and CVD compared with the general population. The results from mandatory cardiovascular outcome trials (CVOTs) are therefore of great interest in the field. The Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes meeting progra...
The most valuable texts of 2017, as chosen by AJN's panel of judges.
AJN takes a look back at some of the health care achievements (and disappointments) of 2017.
[This corrects the article on p. 219 in vol. 13, PMID: 29066941.].
In this issue of Cell Chemical Biology, Tichá et al. (2017) report a novel class of highly potent and selective rhomboid inhibitors. Rhomboids are implicated in several devastating human afflictions including malaria, diabetes, cancer, and Parkinson's disease (PD), making them important drug targets for future therapeutics.
Exosomes are small membrane vesicles secreted by most cell types that play an important role in intercellular communication. Due to the characteristic of transferring their biomacromolecules, exosomes have potential as a new alternative for delivering protein therapeutics. Here, we investigate whether exosomes provide crucial advantages over other nanoparticles, in particular protein nanocage formulations, as a delivery system for membrane protein therapeutics. We characterized membrane-scaffold-based exoso...
Six months of adjuvant oxaliplatin-based chemotherapy is standard for patients with stage III colon cancer following surgery. However, oxaliplatin is associated with peripheral neurotoxicity which worsens over treatment duration. Consequently, a shorter treatment duration, if equally effective would be extremely beneficial. A pooled analysis of data for 12,834 stage III colon cancer patients, from six randomised phase III trials of adjuvant therapy, the IDEA study, was performed and the results presented at...